Nausea
📧 Sign up to get email alerts when something new happens for Nausea.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-03-03Clinical Trial Update: Efficacy and Tolerability of Combination Varenicline With Hydroxyzine as a Potential Smoking Cessation Treatment [Phase 4]
A Phase 4 trial evaluated the efficacy and tolerability of combining varenicline with hydroxyzine as a potential treatment for smoking cessa…
-
CLINICAL_TRIALS trial_result · 2022-12-28Clinical Trial Update: Scopolamine Patch and Acupressure Point P6 Stimulation for Reduction of Nausea and Vomiting During Cesarean Section [Phase 4]
Phase 4 trial evaluating scopolamine patch and acupressure at P6 for reducing nausea and vomiting during cesarean section; results posted in…
-
FDA approval · 2022-07-14FDA Approved: PROCHLORPERAZINE EDISYLATE — Original Application (Eugia US LLC)
FDA approves the original application for Prochlorperazine edisylate (generic) by Eugia US LLC.
-
EMA withdrawal · 2022-04-08EMA Withdrawn: Palonosetron Hospira (palonosetron hydrochloride) — Pfizer Europe MA EEIG
Palonosetron Hospira (palonosetron hydrochloride) has been withdrawn in the EMA system.
-
FDA approval · 2022-03-15FDA Approved: ONDANSETRON — Supplemental Application (Hospira, Inc.)
FDA approves Hospira, Inc.'s supplemental application for ondansetron, authorizing changes to the approved product.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-03-11FDA Approved: ONDANSETRON — Supplemental Application (JVET PHARMACEUTICALS LLC)
The FDA approved a supplemental application for ondansetron from JVET PHARMACEUTICALS LLC, enabling this generic product's expanded approval…
-
CLINICAL_TRIALS trial_result · 2022-01-21Clinical Trial Update: The Optimization of Antiemetic Regimen for C-RINV in LA-HNSCCs [Phase 2]
Phase 2 trial update on optimizing antiemetic regimen for radiotherapy-induced nausea and vomiting in locally advanced head and neck squamou…
-
FDA approval · 2021-09-28FDA Approved: PROCHLORPERAZINE EDISYLATE — Original Application (Cosette Pharmaceuticals, Inc.)
FDA approves Cosette Pharmaceuticals' prochlorperazine edisylate as an original generic application for use as an antiemetic.
-
FDA approval · 2021-07-12FDA Approved: PROMETHAZINE HYDROCHLORIDE — Original Application (QUAGEN PHARMACEUTICALS LLC)
FDA approved promethazine hydrochloride under an original ANDA for Quagen Pharmaceuticals LLC.
-
FDA approval · 2021-04-22FDA Approved: PROCHLORPERAZINE EDISYLATE — Original Application (Caplin Steriles Limited)
FDA approved the original application for PROCHLORPERAZINE EDISYLATE (Caplin Steriles Limited), a prochlorperazine edisylate antiemetic prod…
-
CLINICAL_TRIALS trial_result · 2021-03-24Clinical Trial Update: EMS Use of Isopropyl Alcohol Aromatherapy Versus Ondansetron [NA]
Completed clinical trial comparing isopropyl alcohol aromatherapy versus ondansetron for nausea; results posted.
-
CLINICAL_TRIALS trial_result · 2021-03-23Clinical Trial Update: Efficacy of Aprepitant (Emend®) in Children [Phase 3]
Phase 3 trial evaluating the efficacy of Aprepitant (Emend) in children for nausea and vomiting, completed.
-
CLINICAL_TRIALS trial_result · 2020-07-23Clinical Trial Update: Isopropyl Alcohol vs Ondansetron for Nausea in the Emergency Department [Phase 4]
Phase 4 clinical trial comparing isopropyl alcohol and ondansetron for nausea in the emergency department has completed with results posted.
-
FDA approval · 2020-06-25FDA Approved: PROCHLORPERAZINE EDISYLATE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for Prochlorperazine Edisylate from Heritage Pharmaceuticals (d/b/a Avet Pharmaceuticals).
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: Minimizing Nausea and Vomiting During Spinals for CS [Phase 4]
Phase 4 trial update on minimizing nausea and vomiting during spinal procedures, with terminated status and posted results.
-
EMA withdrawal · 2020-03-02EMA Withdrawn: Varuby (rolapitant) — TESARO Bio Netherlands B.V.
EMA has withdrawn Varuby (rolapitant) from the market in the Netherlands/EMA record; the withdrawal concerns vomiting, nausea, and cancer in…
-
FDA approval · 2020-02-05FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Chlorpromazine Hydrochloride from Hikma Pharmaceuticals USA Inc.
-
CLINICAL_TRIALS trial_result · 2019-12-19Clinical Trial Update: Effect of Ginger on Nausea and Vomiting During Acute Gastroenteritis in Children [Phase 2]
Phase 2 trial evaluating the effect of ginger on nausea and vomiting during acute gastroenteritis in children has been completed.
-
CLINICAL_TRIALS trial_result · 2019-11-29Clinical Trial Update: Pregabalin for the Prevention of Chemotherapy Induced Nausea and Vomiting [Phase 2]
Phase 2 clinical trial update investigating pregabalin for prevention of chemotherapy-induced nausea and vomiting.
-
CLINICAL_TRIALS trial_result · 2019-10-25Clinical Trial Update: Hemodynamic Protection of Preoperative Ondansetron 15 Minutes Before Spinal Anaesthesia in Caesarean Section [Phase 3]
Phase 3 trial completed evaluating preoperative ondansetron given 15 minutes before spinal anaesthesia to protect hemodynamics during cesare…
-
CLINICAL_TRIALS trial_result · 2019-10-14Clinical Trial Update: A Study in Opioid-Experienced, Non-Dependent Recreational Drug Users to Determine the Abuse Potential and Safety of CL-108 Tablets Administered Via the Oral Route [Phase 1]
Phase 1 trial assessing abuse potential and safety of CL-108 tablets in opioid-experienced, non-dependent recreational drug users; completed…
-
CLINICAL_TRIALS trial_result · 2019-10-07Clinical Trial Update: Intrathecal Atropine vs IV Metoclopramide for Nausea & Vomiting During CS [Phase 4]
Phase 4 clinical trial comparing intrathecal atropine to IV metoclopramide for nausea and vomiting during cesarean section, completed.
-
CLINICAL_TRIALS trial_result · 2019-09-19Clinical Trial Update: Sublingual Tablets With Cannabinoid Combinations for the Treatment of Dysmenorrhea [Phase 2]
Phase 2 clinical trial exploring sublingual tablets with cannabinoid combinations for dysmenorrhea and related symptoms.
-
CLINICAL_TRIALS trial_result · 2019-06-04Clinical Trial Update: Post-Operative Therapy for Nausea or Vomiting [Phase 4]
Phase 4 clinical trial update on post-operative therapy for nausea and vomiting; the study was terminated and results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-03-07Clinical Trial Update: Subcutaneous Route and Pharmacology of Metoclopramide [Phase 3]
Phase 3 trial update on subcutaneous administration and pharmacology of metoclopramide for nausea and vomiting.